Revvity, Inc. (RVTY): Operating Cash Flow
$582.93M
Year ended 2025-12-28
$627.63M
Trailing 12 months to 2026-07-05
-5.0%
3-year compound annual growth
-8.2%
5-year compound annual growth
+7.3%
10-year compound annual growth
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-28 | $582.93M | -7.2% | 2026-02-24, From 2024-12-30 |
| 2024-12-29 | $628.30M | +588.4% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $91.27M | -86.6% | 2026-02-24, From 2023-01-02 |
| 2023-01-01, Fiscal 2022 | $679.81M | -51.8% | 2025-02-25, From 2022-01-03 |
| 2022-01-02, Fiscal 2021 | $1.41B | +58.1% | 2024-02-27, From 2021-01-04 |
| 2021-01-03, Fiscal 2020 | $892.18M | +145.5% | 2023-03-01, From 2019-12-30 |
| 2019-12-29 | $363.47M | +16.9% | 2022-03-03, From 2018-12-31 |
| 2018-12-30 | $311.04M | +7.8% | 2021-03-02, From 2018-01-01 |
| 2017-12-31 | $288.45M | -17.7% | 2020-02-25, From 2017-01-02 |
| 2017-01-01, Fiscal 2016 | $350.62M | +22.1% | 2019-02-26, From 2016-01-04 |
| 2016-01-03, Fiscal 2015 | $287.10M | +2.0% | 2018-02-27, From 2014-12-29 |
| 2014-12-28 | $281.60M | +77.6% | 2017-02-28, From 2013-12-30 |
| 2013-12-29 | $158.59M | +4.2% | 2016-03-01, From 2012-12-31 |
| 2012-12-30 | $152.17M | -32.3% | 2015-02-24, From 2012-01-02 |
| 2012-01-01, Fiscal 2011 | $224.87M | +36.9% | 2014-02-25, From 2011-01-03 |
| 2011-01-02, Fiscal 2010 | $164.25M | +10.4% | 2013-02-26, From 2010-01-04 |
| 2010-01-03, Fiscal 2009 | $148.72M | -31.7% | 2012-02-28, From 2008-12-29 |
| 2008-12-28 | $217.84M | n/a | 2011-03-01, From 2007-12-31 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Revvity, Inc. (RVTY) | 2025-12-28 | $582.93M | -7.2% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $532.20M | +16.9% |
| Waters Corp (WAT) | 2025-12-31 | $652.55M | -14.4% |
| Bruker Corp (BRKR) | 2025-12-31 | $134.10M | -46.6% |
| Mettler Toledo International Inc (MTD) | 2025-12-31 | $955.77M | -1.3% |
| Illumina, Inc. (ILMN) | 2025-12-28 | $1.08B | +28.9% |
| Avantor, Inc. (AVTR) | 2025-12-31 | $623.80M | -25.8% |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $1.56B | -11.0% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $136.05M | n/m |
Compare RVTY, BIO, WAT, BRKR side by side · Screen every company in Laboratory Analytical Instruments ↗